RxDoctor Payments Data

Luis Castro, DO

Family Medicine · Miami, FLNPI 1396902789

Payments from drug & device makers

$1,305in general payments, 2019–2025

Across 61 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$236
  • Lilly USA, LLC$149
  • Boehringer Ingelheim$141
  • Novo Nordisk$127
  • Johnson & Johnson$82
  • Abbott$66
  • plus $502 from 17 others

What the payments were for

  • Food & beverage$1,24796%
  • Education$202%
  • Other$383%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,305 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$76,985
Medicare patients
120
Services billed
1,759

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium14$1,622
Rosuvastatin Calcium83$1,311
Atorvastatin Calcium42$851
Levothyroxine Sodium35$671
Losartan Potassium40$498
Omeprazole29$474
Tamsulosin Hcl18$441
Metformin Hcl41$396
Amlodipine Besylate23$297
Naproxen Sodium15$284
Metoprolol Succinate15$272
Temazepam23$260
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$224
Finasteride11$175
Meloxicam17$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$56$1,62214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →